Author:
Jayasudha A. V.,Nair Rekha A.,Renu S.,Binitha R.,Reghu K. S.,Kusumakumary P.
Publisher
Springer Science and Business Media LLC
Reference8 articles.
1. Mehdi I, Shah AH, Moona MS, Verma K, Abussa A, Elramih R et al (2010) Synchronous and metachronous malignant tumours expect the unexpected. J Pak Med Assoc 60:905–909
2. Heyn R, Khan F, Ensign LG et al (1994) Acute myeloid leukemia in patients treated for rhabdomyosarcoma with cyclophosphamide and low dose etoposide on intergroup rhabdomyosarcoma study 111: an interim report. Med Pediatr Oncol 23:99–106
3. Meadows AT, Friedman DL, Neglia JP, Mertens AC, Donaldson SS, Stovall M et al (2009) Second neoplasm in survivors of childhood cancer: findings from the childhood cancer survior study cohort. J Clin Oncol 27:2356–2362
4. Perilongo G, Felix CA, Meadows AT, Nowell P, Biegel J, Lange BJ (1993) Sequential development of Wilms tumor, T-cell acute lymphoblastic leukemia medulloblastoma and myeloid leukemia in a child with type I neurofibromatosis: a clinical and cytogenetic case report. Leukemia 7:912–915
5. Anensen N, Skavland J, Stapnes C, Ryningen A, Borresen-Dale AL, Gjertsen BT et al (2006) Acute myelogenous leukemia in a patient with Li–Fraumeni syndrome treated with valproic acid, theophyllamine and all-trans retinoic acid: a case report. Leukemia 20:734–736